Guru Ownership Trend
Guru Analysis for Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals, Inc. (CRVS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $231,575.76.
Top institutional holders include Paul Tudor Jones.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.27 M net outflow during the quarter.
On the selling side, Paul Tudor Jones reduced exposure by 20.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Corvus Pharmaceuticals, Inc. (CRVS)
Major holders include Paul Tudor Jones ($328,560). According to the latest reported data, 1 tracked investment managers collectively hold approximately 21,992 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.27 M, with 0 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited CRVS. The total reported sell value was $1.27 M.
No tracked managers opened new positions or increased their holdings in CRVS during the most recent reporting period.